Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenal Function and Intralesional Kenalog-10 in Alopecia Areata
NCT00484679Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- May 2007
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triamcinolone acetonide in alopecia areata, sponsored by University of Minnesota. Primary endpoint: Mean Change in Cortisol Levels From Baseline to Week 24. Started May 2007; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT00484679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00484679.